ATRA earnings: a negative outcome, -7.7%

On February 8, 2023, Atara Biotherapeutics, Inc. reached its earnings. The result was a negative outcome, and the stock moved -7.7% in the window around the event. It had already run +47.3% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.